<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="molecules-25-02529-t002" orientation="portrait" position="float">
 <object-id pub-id-type="pii">molecules-25-02529-t002_Table 2</object-id>
 <label>Table 2</label>
 <caption>
  <p>Free binding energies of the drugs to the SARS-CoV-2 main protease structure 6LU7.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Approved Drug</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Lowest Free Binding Energy to the Active Site (kcal mol
     <sup>−1</sup>)
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="2" align="left" valign="middle" rowspan="1">
     <bold>HIV-1 protease inhibitors</bold>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Lopinavir</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">−8.65 (2nd)</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Ritonavir</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">−8.96 (2nd)</td>
   </tr>
   <tr>
    <td colspan="2" align="left" valign="middle" rowspan="1">
     <bold>HCV protease inhibitors</bold>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Telaprevir</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">−9.23</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Boceprevir</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">−9.16 (2nd)</td>
   </tr>
   <tr>
    <td colspan="2" align="left" valign="middle" rowspan="1">
     <bold>DPP-4 inhibitor</bold>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Sitagliptin</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">−8.80</td>
   </tr>
   <tr>
    <td colspan="2" align="left" valign="middle" rowspan="1">
     <bold>Thrombin inhibitors</bold>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Argatroban</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">−9.03</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Dabigatran</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">−6.57</td>
   </tr>
   <tr>
    <td colspan="2" align="left" valign="middle" rowspan="1">
     <bold>Factor Xa inhibitor</bold>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Rivaroxaban</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">−7.97</td>
   </tr>
   <tr>
    <td colspan="2" align="left" valign="middle" rowspan="1">
     <bold>ACE inhibitor</bold>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Captopril</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">−5.17</td>
   </tr>
   <tr>
    <td colspan="2" align="left" valign="middle" rowspan="1">
     <bold>Renin inhibitor</bold>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aliskiren</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−4.66</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
